Introduction
============

Optic nerve injury, which occurs in optic atrophy and glaucoma, is a cause of irreversible visual loss. Diseases involving optic nerve injury are characterized by visual field loss, visual acuity loss, and the degeneration of the retinal ganglion cells (RGCs).[@b1-opth-11-1825] The major risk factor for glaucoma is well known to be elevated intraocular pressure (IOP), but it is also recognized that some forms of glaucoma are multifactorial. Thus, to clarify the underlying pathological mechanisms of RGC death in optic nerve injury, several different animal models of axonal injury have been used. Previous studies, some by our own research group, have shown that oxidative stress and endoplasmic reticulum (ER) stress have critical roles in inducing the loss of RGCs.[@b2-opth-11-1825]--[@b7-opth-11-1825] These studies showed that anti-ER stress or/and anti-oxidative stress compound have potential to treat the degeneration of RGCs.

Cytotoxic stimulation such as hypoxia and elevation of calcium levels occurs during the accumulation of unfolded or misfolded protein, and then unfolded protein response (UPR) is induced.[@b8-opth-11-1825] UPR is believed to be a protective mechanism through the elevation of ER chaperone to reduce misfolded protein. However, excess and prolonged ER stress promotes the signaling pathway of apoptosis. Previous studies have reported that the upregulation of chaperone molecules promotes cell survival during ER stress, in vitro and in vivo. In particular, Grp78, a chaperone molecule, has a critical role in suppressing apoptosis,[@b9-opth-11-1825] and Grp94, another chaperone molecule, suppresses neuronal cell death during ischemia/reperfusion injury.[@b10-opth-11-1825] These findings support the view that chaperone molecules such as Grp78 and Grp94 have an important role in protection of injured cells under ER stress.

Flavonoids are natural products which are widely distributed in vegetables and fruits and are well known to exert biological effects.[@b11-opth-11-1825],[@b12-opth-11-1825] Bilberry extract, which contains the flavonoid anthocyanin, has been shown to have a protective effect against cell damage caused by a variety of stress conditions.[@b13-opth-11-1825]--[@b15-opth-11-1825] Therefore, daily consumption of flavonoid-rich foods, such as bilberry extract, may have the potential to prevent various diseases. On the other hand, quercetin, a kind of flavonoid, also has an anti-apoptotic cell death effect during ER stress.[@b16-opth-11-1825] However, it is unknown whether bilberry extract anthocyanin has an anti-ER stress effect directly.

In this study, we determined whether the oral administration of bilberry extract had a neuroprotective effect on the RGCs, and investigated the relationship of this effect with the activation of chaperone molecules that act against ER stress during optic nerve damage.

Materials and methods
=====================

Animals
-------

This study used 10 to 12-week-old male mice (C57BL/6J strain; SLC, Shizuoka, Japan). In total, 56 mice were used. For Western blotting, q-PCR, and immunohistochemical analysis, each experimental group included four mice. For retrograde labeling of RGCs, each experimental group included six mice. Maintenance and handling of the animals followed the guidelines of the Association for Research in Vision and Ophthalmology Statement for Use of Animals in Ophthalmic Vision Research, as well as the Tohoku University Guidelines for Animal Research. The Ethics Committee for Animal Experiments at Tohoku University Graduate School of Medicine approved all experimental procedures.

Bilberry extract administration
-------------------------------

*Vaccinium myrtillus L*. anthocyanoside (bilberry extract) (containing less than 36% anthocyanins) was provided by Wakasa Seikatsu Co., Ltd (Kyoto, Japan). The mice were divided into three groups: Group 1 received phosphate-buffered saline (PBS) as a vehicle, while Groups 2 and 3 received bilberry extract in doses of, respectively, 100 and 500 mg/kg of body weight/day, administered by oral gavage. Oral gavage was performed once a day for 3 days. Animals that also underwent optic nerve crush (NC) received daily oral gavage starting 3 days before NC and ending when the animals were sacrificed.

Optic nerve injury
------------------

Axonal injury was induced in the eyes of the mice as previously described.[@b2-opth-11-1825],[@b17-opth-11-1825] Briefly, the optic nerve was crushed 2 mm posterior to the globe with forceps for 10 seconds, while the animals were under deep anesthesia induced with ketamine (100 mg/kg) and xylazine (9 mg/kg). After the surgical procedure, antibiotic ointment was applied to the treated eyes.

Retrograde labeling and counting of RGCs
----------------------------------------

To determine the number of RGCs in the retinas of the mice, retrograde labeling was performed with 2% Fluorogold (Fluorochrome, Denver, CO, USA) 7 days before optic nerve injury, as previously described.[@b4-opth-11-1825] Seven days after optic nerve injury, the eyeballs were enucleated and fixed in 4% paraformaldehyde (PFA) for 1 h. Retinal flat mounts were then prepared on glass slides, as previously described.[@b18-opth-11-1825] The average number of RGCs was then counted, as previously described.[@b4-opth-11-1825]

Quantitative reverse-transcription polymerase chain reaction (qRT-PCR)
----------------------------------------------------------------------

Retinal samples from mice were collected 3 days after optic NC. Total RNA was extracted from the retinas, and cDNA was synthesized as previously described.[@b19-opth-11-1825] qPCR was performed with a 7500 Fast Real-Time PCR system (Thermo Fisher Scientific, Waltham, MA, USA), as previously described.[@b20-opth-11-1825] Predesigned TaqMan probes (Thermo Fisher Scientific) were used to detect the following genes: *Grp78*: Mm00517690_g1; *Grp94*: Mm00441926_m1; *Chop*: Mm00492097_m1; *Bax*: Mm00432051_m1; *Atf4*: Mm00515324_m1; *Pou4f1*: Mm02343791_m1; *Pou4f2*: Mm00454754_s1; *Pou4f3*: Mm04213795_s1; and *Gapdh*: Mm99999915_g1. Relative gene expression was calculated using the delta-delta Ct method, normalized to *GAPDH* mRNA.

Western blotting
----------------

Retinal proteins were extracted with RIPA buffer, and their concentrations were measured with a BCA assay (Thermo Fisher Scientific). Ten micrograms of mouse retinal proteins were separated in 10% polyacrylamide gel with SDS-PAGE and transferred onto an Immobilon-P membrane (Merck-Millipore, Darmstudt, Germany). The membranes were blocked with 4% block ACE (DS pharma biomedical, Osaka, Japan) and incubated with rabbit anti-Grp78 (Bip) (1:250, ab21685; Abcam, Cambridge, UK) or rat anti-Grp94 (1:250, ADI-SPA-850-F; Enzo Life Sciences, Exeter, UK) as the primary antibodies overnight at 4°C, and then incubated with HRP-conjugated secondary antibodies. Immunoblots were visualized with ECL prime detection reagent (GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA), and the immunoreactive bands were captured with ChemiDoc XRS (Bio-Rad Laboratories Inc., Hercules, CA, USA).

Immunohistochemistry
--------------------

The eyes of the mice were perfused with 4% PFA and cryosections were prepared, as previously described.[@b4-opth-11-1825] The cryosections were washed in 0.05% Tween 20 in PBS (Tw-PBS) and incubated in blocking buffer (10% donkey serum containing 2% Tx-100 in PBS) for 30 min at room temperature. The cryosections were then incubated overnight at 4°C in a blocking buffer containing rabbit anti-Grp78 (1:100) or rat anti-Grp94 (1:100) as primary antibodies. After washing in Tw-PBS, the cryosections were then incubated with Alexa Fluor 488-conjugated donkey anti-rabbit or anti-rat antibodies (Thermo Fisher Scientific) for 1 h at room temperature. The sections were then mounted with Vectashield mounting medium containing DAPI (Vector Laboratories, Burlingame, CA, USA), and the fluorescence signal was captured with a fluorescence microscope (Axiovert 200; Carl Zeiss Meditec AG, Jena, Germany).

Statistical analysis
--------------------

Statistical comparisons were made with an ANOVA followed by Dunnett's test to compare the mean in three groups and unpaired *t*-test to compare two samples. The significance level was set at *P*\<0.05.

Results
=======

Bilberry extract administration up-regulated chaperone molecules in the mouse retinas
-------------------------------------------------------------------------------------

The immunoblot analysis revealed the presence of Grp78 and Grp94 in the retinas 3 days after the administration of bilberry extract ([Figure 1A](#f1-opth-11-1825){ref-type="fig"}). In the retinas of mice that received 100 or 500 mg/kg/day of bilberry extract, the protein level of Grp78 was \~2.6 fold and \~3.2 fold higher, respectively, than in the retinas of the PBS-treated control mice ([Figure 1B](#f1-opth-11-1825){ref-type="fig"}). Additionally, the protein level of Grp94 was \~1.4 fold higher than in PBS-treated controls, a significant difference in the mice that received 500 mg/kg/day of bilberry extract ([Figure 1C](#f1-opth-11-1825){ref-type="fig"}). However, the mRNA levels of Grp78 and Grp94 did not significantly differ in the mice that did or did not receive bilberry extract treatment ([Figure 1D and E](#f1-opth-11-1825){ref-type="fig"}), suggesting that the upregulation of Grp78 and Grp94 does not depend on their transcriptional levels, and might be regulated during post-translational stabilization. To determine the type of cells that up-regulated the Grp78 and Grp94 proteins, we performed an immunohistochemical analysis targeting Grp78 and Grp94. Immunostaining with an anti-Grp78 antibody showed that the location of Grp78 was mainly surrounding the nuclei in the ganglion cell layer (GCL) and inner nuclear layer (INL) in PBS-treated mice. In a group of mice treated with 500 mg/kg/day of bilberry extract, Grp78 protein was mostly up-regulated in the GCL. After treatment with bilberry extract, Grp78 and Grp94 proteins were up-regulated in the GCL, suggesting that this treatment modulated the protein levels of Grp78 and Grp94 in the GCL specifically, and that bilberry treatment may provide pre-conditioning for RGC protection caused by ER stress. Grp78 and Grp94 protein was up-regulated mostly in the GCL, INL, and outer plexiform layer after the administration of 100 or 500 mg/kg/day bilberry extract for 3 days ([Figure 2A and B](#f2-opth-11-1825){ref-type="fig"}). To determine potential side effects, we measured the body weight of the mice during treatment with bilberry extract. There were no significant changes in body weight between the vehicle-treated and bilberry-administered groups. Details of increases in body weight in each group are as follows: 3 days after PBS treatment, 0.6±0.5 g; after 100 mg/kg bilberry treatment, 0.4±0.3 g; and after 500 mg/kg bilberry treatment, 0.7±0.3 g (a one-way ANOVA showed no significant difference between the three groups; [Table 1](#t1-opth-11-1825){ref-type="table"}). No mice died during PBS or bilberry treatment. These results suggest that there were no side effects or toxicity issues associated with bilberry extract administration.

Bilberry extract administration ameliorated the induction of ER stress and RGC degeneration
-------------------------------------------------------------------------------------------

After optic nerve injury, ER stress has been shown to induce progressive RGC death by activating apoptosis.[@b21-opth-11-1825]--[@b23-opth-11-1825] Thus, this study evaluated the expression levels of genes involved in ER stress and apoptosis. Three days after optic NC, the gene expression levels of *Chop* and *Bax* were significantly higher (\~2.1 fold and \~2.0 fold, respectively) than in animals that underwent a sham operation ([Figure 3A](#f3-opth-11-1825){ref-type="fig"}). However, bilberry extract administration significantly suppressed the induction of *Chop*, *Bax*, and *Atf4* gene expression 3 days after optic NC, in comparison with mice that received only PBS ([Figure 3A](#f3-opth-11-1825){ref-type="fig"}). In addition, the transcriptional level of *Pou4f2* and *Pou4f3*, specific RGC markers, was higher (\~2.2 fold and \~2.3 fold, respectively) in the retinas of mice that received bilberry extract than those of mice that received only PBS 3 days after optic NC ([Figure 3B](#f3-opth-11-1825){ref-type="fig"}). Furthermore, the average number of retrogradely labeled RGCs in the retina was higher (\~1.2 fold) after bilberry extract administration than after the administration of PBS 7 days after optic NC ([Figure 4A and B](#f4-opth-11-1825){ref-type="fig"}).

Discussion
==========

In this study, we showed that bilberry extract administration induced elevated levels of molecular chaperones in the retinas of mice. This induction of chaperone molecules might contribute to RGC protection by suppressing ER stress. This finding suggests that bilberry extract has a role in preventing ER stress and RGC death in the mouse retina after optic nerve injury. Previous work demonstrates that intravitreal injection of bilberry extract protects against excitotoxic damage induced by NMDA in the mouse retina.[@b13-opth-11-1825] In addition, oral administration of bilberry extract ameliorates retinal damage caused by factors such as oxidative stress, photoreceptor damage, and the inflammatory response in the eyes of mice with endotoxin-induced uveitis.[@b14-opth-11-1825] The novelty of the current study was its focus on the rescue of RGCs in an optic NC model, which is known to reflect glaucomatous damage in human subjects. Moreover, we investigated the oral administration of bilberry extract, to determine the potential of dietary supplementation with bilberry extract for glaucoma treatment. Previous work on the oral administration of bilberry extract showed that it protected the gastric mucosa against ethanol-induced gastric ulcers by suppressing free radicals.[@b24-opth-11-1825] Thus, taking into consideration previous work, our results may show that supplements containing bilberry extract can usefully protect against RGC damage in glaucoma, in addition to mitigating the inflammatory response and gastric ulcers.

Chaperone molecules are a class of proteins, the functions of which include the regulation of homeostasis and protection against ER stress.[@b25-opth-11-1825] Among these molecules, Grp78 in particular has been shown to prevent ER stress-related cell death during the UPR.[@b26-opth-11-1825] Previous work reported that Grp78 mediates CHOP suppression and reduces CHOP-dependent apoptosis.[@b27-opth-11-1825] Furthermore, the PI3K/AKT pathway is activated by Grp78 on the cell surface.[@b28-opth-11-1825] Additionally, glutamine metabolism, which contributes to cell survival, is promoted by c-Myc, which is induced by Grp78.[@b29-opth-11-1825] These findings indicate that Grp78 acts to attenuate ER stress-dependent cell death and promote cell survival by facilitating the activation of several signaling and metabolism pathways. Grp94 is also induced by various stresses, including ER stress and glucose starvation.[@b30-opth-11-1825] Adenovirus-mediated Grp94 overexpression suppresses neuronal cell death under oxidative stress and ischemic conditions, and perturbs calcium homeostasis.[@b10-opth-11-1825],[@b31-opth-11-1825] In addition, silencing Grp94 with siRNA increases apoptosis induced by actinomycin D treatment in vitro, indicating that reduced Grp94 promotes apoptosis.[@b32-opth-11-1825] In the field of ophthalmology, many studies have shown that optic nerve damage augments ER stress, as well as oxidative stress, in the RGCs,[@b2-opth-11-1825]--[@b4-opth-11-1825],[@b23-opth-11-1825] and drugs with anti-ER and anti-oxidative stress effects have been shown to reduce RGC loss.[@b4-opth-11-1825],[@b33-opth-11-1825]--[@b37-opth-11-1825] Therefore, our finding that bilberry extract administration increased the level of chaperone molecules, which are known to suppress ER stress, suggests that treatment with bilberry extract may be a promising way to prevent retinal and optic nerve damage in diseases such as glaucoma. We investigated Grp78 and Grp94 expression after optic NC in mice that received bilberry extract. We found that the protein level of Grp78 and Grp94 was slightly increased in the bilberry extract administration group 3 days after NC, similar to bilberry extract administration group without NC ([Figure S1](#SD1-opth-11-1825){ref-type="supplementary-material"}). However, the induction level of Grp78 and Grp94 protein in healthy mice was clearly higher than that in mice with NC-injured retinas. These findings suggest that pre-conditioning for Grp78 and Grp94 upregulation might be a crucial event in the mechanism of RGC protection after optic nerve injury in mice. However, detailed information on the mechanisms by which Grp78 and Grp94 modulate the cell survival pathway in the RGCs is unavailable at present, and needs to be elucidated in future studies.

In damaged neurons, unfolded proteins accumulate and induce cell death. In the retina of glaucoma mice model, after optic nerve injury, the ER stress pathway is activated and RGC death occurs.[@b2-opth-11-1825],[@b38-opth-11-1825] In *Chop* knockout mice, RGC death is reduced after optic NC.[@b23-opth-11-1825] Thus, CHOP is considered a promising target for therapies to reduce RGC loss caused by ER stress after optic nerve injury. Atf4 is a transcriptional factor activated under ER stress and induces the expression of Chop, leading to ER stress-induced apoptosis.[@b39-opth-11-1825] Our previous work suggested that the ATF4-CHOP pathway is the key upstream pathway inducing RGC loss during ER stress, which occurs in the early stages of axonal injury.[@b2-opth-11-1825] In addition, prolonged ER stress promotes apoptosis via Bax activation and subsequent CHOP signaling.[@b40-opth-11-1825] The current study obtained novel findings showing that bilberry extract administration suppressed the gene expression of *Chop*, *Bax*, and *Atf4*, suggesting that the mechanism of RGC preservation after the administration of bilberry extract anthocyanins may involve suppression of the CHOP pathway and modulation of the presence of chaperone molecules. Nevertheless, bilberry extract contains several kinds of anthocyanins, and while previous studies have demonstrated the anti-apoptotic effects of bilberry extract and/or its main anthocyanidin constituents (cyanidin, delphinidin, and malvidin),[@b13-opth-11-1825] the current study could not identify the specific anthocyanin type that functions to elevate chaperone molecules in the RGCs. Thus, detailed information on the molecular mechanism underlying the regulation of chaperone molecule levels by bilberry extract remains unknown. This point awaits future investigation.

Conclusion
==========

This study found that bilberry extract administration increased the levels of chaperone molecules in the mouse retina, and that bilberry extract administration prevented RGC loss after optic nerve injury. Furthermore, bilberry extract treatment prevented changes in the expression of genes related to ER stress. Therefore, these findings indicate that treatment with bilberry extract induces the expression of chaperone molecules, suppressing ER stress and preventing RGC loss.

Supplementary material
======================

###### 

Upregulation of chaperone molecules in the mouse retina 3 days after treatment with bilberry extract.

**Notes:** Immunoblot analysis showing the protein expression of Grp78 (**A**) and Grp94 (**B**). GAPDH was used as a loading control.

**Abbreviations:** M, molecular marker; NC, nerve crush.
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![Upregulation of chaperone molecules in the mouse retina 3 days after treatment with bilberry extract.\
**Notes:** (**A**) Immunoblot analysis showing the protein expression of Grp78 and Grp94. GAPDH was used as a loading control. The relative expression levels of Grp78 (**B**) and Grp94 (**C**) were normalized to Gapdh, as shown in the histograms. Error bars show SD (n=4). The relative transcriptional expression of *Grp78* (**D**) and *Grp94* (**E**) was determined with qRT-PCR and was normalized to Gapdh. Error bars show SD (n=4). \*\**P*\<0.01, Dunnett's post hoc comparison test.\
**Abbreviations:** M, molecular marker; qRT-PCR, quantitative reverse-transcription polymerase chain reaction.](opth-11-1825Fig1){#f1-opth-11-1825}

![Localization of chaperone molecules in the mouse retina 3 days after treatment with bilberry extract.\
**Notes:** Representative immunohistochemistry images showing the upregulation of Grp78 (**A**) and Grp94 (**B**) in the ganglion cell layer, inner nuclear layer, and outer plexiform later after treatment with bilberry extract. Scale bars: 20 μm.\
**Abbreviations:** GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer.](opth-11-1825Fig2){#f2-opth-11-1825}

![Gene expression of ER stress markers and RGC markers 3 days after optic nerve crush and treatment with bilberry extract (500 mg/kg/day).\
**Notes:** (**A**) The relative expression levels of *Chop*, *Bax*, and *Atf4* mRNA were measured with qRT-PCR, normalized to Gapdh mRNA. (**B**) The relative expression levels of *Pou4f1*, *Pou4f2*, and *Pou4f3* mRNA after optic nerve crush were measured with qRT-PCR, normalized to *Gapdh*. Error bars indicate SD (n=4). \**P*\<0.05, \*\**P*\<0.01, unpaired *t*-test.\
**Abbreviations:** ER, endoplasmic reticulum; NT, nontreated; NC, nerve crush; PBS, phosphate-buffered saline; qRT-PCR, quantitative reverse-transcription polymerase chain reaction; RGC, retinal ganglion cell.](opth-11-1825Fig3){#f3-opth-11-1825}

![Prevention of RGC degeneration after treatment with bilberry extract (500 mg/kg/day).\
**Notes:** (**A**) Representative image of retrogradely labeled RGCs 7 days after NC and the administration of PBS (left) or bilberry extract (right). Scale bar: 100 μm (applies to both images). (**B**) Histogram showing the ratio of the average number of retrogradely labeled RGCs 7 days after NC and the administration of PBS (left) or bilberry extract (right). Error bars denote SD (n=6). \**P*\<0.05, unpaired *t*-test.\
**Abbreviations:** NC, nerve crush; PBS, phosphate-buffered saline; RGC, retinal ganglion cell.](opth-11-1825Fig4){#f4-opth-11-1825}

###### 

Body weight measurement after bilberry extract administration

  Oral treatment       Body weight (before treatment)   Body weight (3 days after treatment)   Body weight (increase)
  -------------------- -------------------------------- -------------------------------------- ------------------------
  PBS as vehicle       25.7±1.6 g                       26.3±1.6 g                             0.6±0.5 g
  100 mg/kg bilberry   24.5±1.3 g                       25.0±1.4 g                             0.4±0.3 g
  500 mg/kg bilberry   25.8±1.8 g                       26.3±1.6 g                             0.7±0.3 g

**Note:** Data presented as mean ± standard deviation.

**Abbreviation:** PBS, phosphate-buffered saline.
